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Duchenne muscular dystrophy • mdx dystrophic miceABSTRACTMuscle regeneration depends on satellite cells (SCs), quiescent precursors that, in consequenceof injury or in pathological states such as muscular dystrophies, activate, proliferate, and differ-entiate to repair the damaged tissue. A subset of SCs undergoes self-renewal, thus preservingthe SC pool and its regenerative potential. Unacylated ghrelin (UnAG) is a circulating hormonethat protects muscle from atrophy, promotes myoblast differentiation, and enhances ischemia-induced muscle regeneration. Here we show that UnAG increases SC activity and stimulates Parpolarity complex/p38-mediated asymmetric division, fostering both SC self-renewal and myo-blast differentiation. Because of those activities on different steps of muscle regeneration, wehypothesized a beneficial effect of UnAG in mdx dystrophic mice, in which the absence of dys-trophin leads to chronic muscle degeneration, defective muscle regeneration, fibrosis, and, atlater stages of the pathology, SC pool exhaustion. Upregulation of UnAG levels in mdx micereduces muscle degeneration, improves muscle function, and increases dystrophin-null SC self-renewal, maintaining the SC pool. Our results suggest that UnAG has significant therapeuticpotential for preserving the muscles in dystrophies. STEM CELLS 2017;35:1733–1746SIGNIFICANCE STATEMENT
Muscle dystrophies (MDs) are pathologies characterized by chronic degeneration of muscles.
This induces a sustained and continuous regeneration that depends on satellite cells (SCs).
Defective regeneration and SC pool exhaustion ultimately lead to the replacement of muscles
with scar tissue and loss of functionality. Unacylated ghrelin (UnAG) is a circulating hormone
with protective activities on skeletal muscles. Here we demonstrated that UnAG helps to main-
tain the pool of SCs and that it has a beneficial effect on muscles of dystrophic mice. UnAG
could represent a novel treatment for MDs, either alone or as an adjuvant therapy for one of
the promising stem cell-based therapies.INTRODUCTION
Injuries or pathological states such as muscular
dystrophies trigger regeneration in the adult
skeletal muscle. Muscle regeneration is mainly
sustained by a heterogeneous population of
quiescent resident precursors, called satellite
cells (SCs), characterized by the expression of
the transcriptional factor Pax7 [1]. In conse-
quence of injury, SCs activate, proliferate, and
eventually differentiate to repair the damaged
tissue and restore muscle function. A portion
of SCs undergoes self-renewal through asym-
metric division, thus maintaining the quiescent
SC pool and allowing the muscle to retain its
regenerative potential [2, 3]. The asymmetric
division generates two daughter cells with diver-
gent fates: one proliferating myoblast expressing
the marker of myogenic commitment MyoD
(MyoD1) and one MyoD– quiescent SC preserv-
ing stem features. The differential expression of
MyoD depends on the asymmetric segregation
of the Par polarity complex during SC activation
that leads to a polarized activation of p38 MAPK
pathway, triggering MyoD expression in only one
daughter cell [4, 5].
Ghrelin and unacylated ghrelin (UnAG) are
circulating peptide hormones mainly produced
by the stomach. Ghrelin derives from the
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octanoylation of the preprohormone by the ghrelin-O-
acyltransferase (GOAT) enzyme [6, 7]. Acylation is required for
the binding to the growth hormone secretagogue receptor-1a
(GHSR-1a) to induce growth hormone release and to perform
multiple endocrine functions [8, 9]. UnAG, the main circulat-
ing form of the peptide, does not bind to GHSR-1a but fea-
tures several biological activities, including the enhancement
of skeletal muscle regeneration induced by hindlimb ischemia
[10, 11] and improvement of insulin sensitivity in skeletal
muscle [12, 13]. Besides, UnAG shares with ghrelin numerous
biological effects, among which the protection of skeletal
muscle from atrophy [14, 15] and the promotion of myoblast
differentiation [16].
While the mechanisms through which UnAG protects skel-
etal muscle from atrophy and insulin resistance have been
described [12–14], the cellular and molecular mechanisms
mediating UnAG ability to enhance muscle regeneration
remain to be elucidated. Here we show that UnAG affects
multiple stages of muscle regeneration, including SC activa-
tion, proliferation, and self-renewal, the latter through induc-
tion of SC asymmetric division mediated by PKCk/i-Par6
complex formation and asymmetric activation of p38. More-
over, UnAG induces the differentiation of committed myo-
blasts, thus promoting the regeneration of injured muscles.
Based on UnAG ability to enhance skeletal muscle regenera-
tion, we hypothesized that UnAG could have a therapeutic
importance for muscle dystrophies. Duchenne muscular dystro-
phy (DMD) is characterized by the absence of the dystrophin
protein, whose main function is to connect the myofiber cyto-
skeleton to the extracellular matrix through the dystrophin-
associated glycoprotein complex. In the absence of dystrophin,
myofibers are extremely susceptible to contraction-induced
damage, with the consequent chronic degeneration [17]. More-
over, dystrophin-null SCs display an impairment of self-renewal
and asymmetric division that results in a faulty myogenic pro-
gression and, thus, in a defective regenerative process [18, 19].
We show that upregulation of circulating or local UnAG levels
in mdx mice improves the dystrophic phenotype, including
muscle architecture and functionality. Moreover, UnAG blunts
the self-renewal defect of dystrophin-null SCs, thus preserving
the SC pool at later stages of the pathology.MATERIALS AND METHODSAnimals
Animal experiments were performed according to procedures
approved by the Institutional Animal Care and Use Committee
at the University of Piemonte Orientale. Male mice, matched
for age and weight, were used for all experiments. Dystrophin-
deficient mdx mice (C57BL/10ScSn-Dmdmdx/J) and C57BL/6-
Tg(CAG-EGFP)131Osb/LeySopJ mice with ubiquitous GFP expres-
sion were from The Jackson Laboratory (Bar Harbor, ME,
https://www.jax.org/); FVB1-Myh6/Ghrl and C57BL/6-Myh6/
Ghrl transgenic mice were generated as previously described
[14]. Animals were fed ad libitum and had unrestricted access
to drinking water. The light/dark cycle in the room consisted of
12/12 hours with artificial light. To generate dystrophic mice
overexpressing the ghrelin gene, C57BL/6J hemizygous Myh6/
Ghrl male mice were bred to homozygous Dmdmdx/mdx female
mice to yield an equal proportion of male mdxTg1 and mdxTg–
littermate controls. mdx mice bearing Myh6/Ghrl transgene
were identified by PCR genotyping. High levels of plasmatic
UnAG in mdxTg1 were confirmed by EIA kit (SPIbio Bertin
Pharma, Montigny le Bretonneux, France, http://www.bertin-
pharma.com/) according to the manufacturer’s instructions. The
numbers of mice estimated sufficient to detect a difference
between two means as large as 1 SD unit with 80% power and
a significance level of 95% at Student’s t test were calculated
with the program by R.V. Lenth (www.stat.uiowa.edu/~rlenth/
Power/index.html). The investigators conducting the experi-
ments were blind to the experimental group assessed. The
investigators quantifying the experimental outcomes were
maintained blinded to the animal group or intervention. Finally,
the statistic evaluation of the experimental data was performed
by another investigator not directly involved in data collection
and parameter measurement.Reagents
Rat UnAG peptide was purchased from PolyPeptide Laborato-
ries (Strasbourg, France, http://www.polypeptide.com/).
Media and fetal bovine serum (FBS) were from Gibco (Thermo
Fisher Scientific, Ashford, UK, https://www.thermofisher.com/),
horse serum (HS) from PAA (GE Healthcare, Little Chalfont,
UK, http://www3.gehealthcare.com/), and media supple-
ments, unless otherwise specified, were from Sigma-Aldrich
(Paisley, UK, http://www.sigmaaldrich.com).Cardiotoxin-Induced Muscle Regeneration
Experiments on muscle regeneration were conducted on adult
male FVB1 and FVB1-Myh6/Ghrl mice matched for age and
weight. Cardiotoxin (CTX) from Naja mossambica mossambica
(Latoxan, Portes-le`s-Valence, France, http://www.latoxan.net/)
was dissolved in sterile saline to a final concentration of 10
lM. Mice were anesthetized by isofluorane inhalation and
hindlimbs were shaved and cleaned with alcohol. Tibialis ante-
rior (TA) muscles were injected with 45 ll of CTX with a 30-
gauge needle, with 15 microinjections of 3 ll CTX each in the
mid-belly of the muscle to induce a homogeneous damage.
The TA muscles of the contralateral hindlimbs were injected
with saline. After injection, animals were kept under a warm-
ing lamp until recovery.
For some experiments, immediately after CTX administration,
a single intraperitoneal injection of 5-bromo-20-deoxyuridine
(BrdU) (6 lg/g mouse) was given, followed by BrdU adminis-
tered ad libitum in drinking water (2.5 mg/ml) for 7 days.Histological Analysis
Muscles were trimmed of tendons and adhering nonmuscle
tissue, mounted in Killik embedding medium (Bio-optica,
Milan, Italy, http://www.bio-optica.it/), frozen in liquid-
nitrogen-cooled isopentane, and stored at 2808C. Transverse
muscle sections (7 mm) were cryosectioned from the mid-
belly of each muscle. Sections were stained with hematoxylin/
eosin to reveal general muscle architecture. Images of whole
muscle sections were acquired with the slide scanner Pannor-
amic Midi 1.14 (3D Histech, Budapest, Hungary, http://www.
3dhistech.com/) and cross-sectional areas (CSA) of centro-
nucleated fibers quantified with ImageJ software (v1.49o).
Muscle collagen content was assessed with Masson trichromic
staining.
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To quantify muscle damage and areas of focal necrosis,
1% wt/vol Evans blue dye (EBD) was injected intraperitoneally
(5 ml/g of animal weight). Muscles were collected 20 hours
after EBD injection. Sections 7-lm thick were cryosectioned,
and EBD uptake was detected as red epifluorescence and
quantified as above.SC Isolation and Culture
Primary myoblasts were isolated from the main hindlimb
muscles (TA, gastrocnemius, quadriceps [QUAD], extensor digi-
torum longus [EDL], soleus) and diaphragm. Muscles were cut
with a lancet into small fragments (about 3 mm3) and further
inspected to eliminate, as much as possible, any remaining
connective tissue. The mass was resuspended in 3 ml of 0.1%
pronase and incubated for 1 hour at 378C for digestion. The
suspension was then centrifuged at 400g for 5 minutes and
the pellet resuspended in DMEM 10% HS medium, passed
several times through a serological pipette, filtered through
40 lm strainers, and further centrifuged at 400g for 10
minutes. SCs were separated from fibroblasts and other cells
using the SC Isolation Kit (MACS Miltenyi Biotec, Milan, Italy)
following the manufacturer’s instructions. After isolation, SCs
were either plated on gelatin-coated dishes or immediately
used in muscle transplantation experiments.
Plated cells were cultured in growth medium (GM), Dul-
becco’s Modified Eagle’s Medium (DMEM) with 20% FBS, 10%
HS, 1% chicken embryo extract (CEE, USBiological Life Scien-
ces, Salem, MA, https://www.usbio.net/), and 10 ng/ml FGF-2
(Peprotech Inc., London, U.K., http://www.peprotech.com).
When cells reached 70%–80% of confluence, GM was shifted
into differentiation medium (DM), DMEM with 5% HS for 3
days. UnAG (100 nM) was added simultaneously to DM.SC Transplantation
To facilitate cell engraftment, one day before muscle trans-
plantation, CTX injection was performed in the mid-belly of
TA muscles of recipient mice. SCs were isolated from C57BL/
6-Tg(CAG-EGFP)131Osb/LeySopJ (green fluorescence protein,
GFP) mice and 100,000 cells, resuspended in serum-free
DMEM, were injected in the previously injured recipient
muscles. Contralateral TA muscles were injected with cell-free
DMEM. Muscles were harvested 30 days after injection, fixed
in 4% paraformaldehyde (PFA), and analyzed.Myofiber Isolation and Culture
EDL muscles were digested in 0.2% collagenase type-I in
DMEM for 60–70 minutes at 378C. Muscles were mechanically
dissociated, and single fibers liberated. After extensive wash-
ing, myofibers were either immediately fixed or cultured in
low proliferation medium (LPM, DMEM supplemented with
10% HS and 0.5% CEE) in suspension. UnAG was added in
LPM immediately after fiber seeding. At different time points
after plating (6-72-96 hours) fibers were fixed in 4% PFA for
10 minutes.
For experiments with the chemotherapic drug AraC (Cyto-
sine b-D-arabinofuranoside), myofibers were cultured for 72
hours in F12 medium supplemented with 15% HS and 1 nM
FGF-2 in the presence or absence of 100 nM UnAG and then
incubated with or without 100 lM AraC for 48 hours and
fixed (day 5).
Immunofluorescence
For Pax7 and BrdU detection, tissue sections were fixed in 4%
PFA for 20 minutes, washed, permeabilized with cold methanol
for 6 minutes, and then antigen-retrieved with sodium citrate
(10 mM, 0.05% Tween in PBS) at 958C for 30 minutes. For
blocking the unspecific binding sites, slices were incubated in
4% bovine serum albumin (BSA) for 2 hours at RT and then
with M.O.M. blocking reagent (Vector Laboratories, Burlingame,
CA, https://vectorlabs.com/) for 1 hour at RT. Sections were
stained with an anti-Pax7 antibody (1:100; Developmental Stud-
ies Hybridoma Bank, Iowa City, IA, http://dshb.biology.uiowa.
edu/) and with anti-BrdU antibody (1:300; Bio-Rad, Segrate, MI,
Italy, http://www.bio-rad.com/) overnight at 48C. After washing,
sections were incubated with the appropriate Alexa Fluor Dyes-
conjugated secondary antibody (488-anti-mouse/anti-rabbit or
568-anti-rabbit; Thermo Fisher Scientific) for 1 hour at RT. 40,6-
diamidino-2-phenylindole (DAPI) was incubated for 5 minutes.
For immunofluorescence with anti-laminin (1:200; Dako,
Agilent Technologies, Santa Clara, CA, http://www.agilent.
com/), anti-GFP (1:200; Thermo Fisher Scientific), and anti-
embryonic MyHC (1:20; Developmental Studies Hybridoma
Bank), after fixing, slices were permeabilized with 0.2% triton
in 1% BSA for 15 minutes and blocked with 4% BSA for 30
minutes. One hour of incubation with primary antibodies was
followed by 45 minutes of secondary antibody incubation at
RT.
Images were acquired using the slide scanner Pannoramic
Midi Scanner 1.14 (3D Histech) and quantified with Pannor-
amic viewer software or ImageJ v1.49o software. For immuno-
fluorescence on isolated fibers and on cultured SCs, samples
were fixed in 4% PFA for 10 minutes, permeabilized with 0.5%
triton for 6 minutes and blocked with 4% BSA for 30 minutes.
Primary antibodies to detect Pax7, MyoD (1:500; Santa Cruz
Biotechnology, Dallas, TX, https://www.scbt.com/), myogenin
(1:100; Developmental Studies Hybridoma Bank), and MyHC
(1:100; Developmental Studies Hybridoma Bank) were incu-
bated overnight at 48C, and the secondary antibodies for 45
minutes at RT, followed by 5 minutes of DAPI. Images were
acquired with a Leica CTR5500 B fluorescent microscope
(Leica Biosystems, Wetzlar, Germany, http://www.leicabiosys-
tems.com/) with the Leica Application SuiteX 1.5 software,
and quantification was performed with ImageJ.
To evaluate the asymmetric division events of SC pairs,
MyoD levels in each cell were obtained by subtracting the
background from the nuclear fluorescence intensity (deter-
mined by overlap with DAPI staining). Cell pairs were scored
“asymmetric” when the MyoD nuclear intensity of one daugh-
ter cell was! 1% (“MyoD–“) and the other one was >1%
(“MyoD1”) of the maximal intensity.
Asymmetric distribution of active p38 and PKCk/i was eval-
uated by SC incubation with rabbit or mouse anti-phospho-
p38T180/Y182 (1:200, Cell Signaling Technology, Beverly, MA,
https://www.cellsignal.com/), rabbit anti-p38 (1:200, Cell Signal-
ing Technology), rat anti-CD34 (1:200, BD Biosciences, Cowley,
UK, http://www.bdbiosciences.com/), rabbit anti-PKCk/i (1:200,
Santa Cruz Biotechnology), rabbit anti-syndecan 4 (1:200,
BioVision, Milpitas, CA, http://www.biovision.com/), and mouse
anti-Pax7 (1:100; Developmental Studies Hybridoma Bank) fol-
lowed by the appropriate Alexa Fluor Dyes-conjugated second-
ary antibodies (546 or 647 anti-mouse, 488 anti-rabbit, and 546
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anti-rat; Thermo Fisher Scientific). Nuclei were counterstained
with TO-PRO-3 iodide (1:100 Thermo Fisher Scientific). Images
were acquired with Leica confocal microscope TCS SP2 using a
63X objective, NA5 1.32, equipped with LCS Leica confocal soft-
ware. Asymmetry of phospho-p38T180/Y182 and PKCk/i was
quantified with ImageJ.
For the proximity ligation assay (PLA; Duolink from Sigma-
Aldrich), myofiber-associated SCs were incubated with mouse
anti-PKCk/i (1:200, BD Bioscience) and rabbit anti-PAR3
(1:200, Merck Millipore) then processed according to the
manufacturer’s instructions.Gene Expression Analysis
Total RNA from muscles was extracted by RNAzol. RNA was
retro-transcribed with High-Capacity cDNA Reverse Transcription
Kit (Thermo Fisher Scientific), and real-time PCR was performed
with the StepOnePlus Real-Time PCR System (Thermo Fisher Sci-
entific) using Mm00445450_m1 (Ghrl) and Mm00506384_m1
(Ppif) TaqMan assays.Hanging Test
A wire-hanging test was used to assess whole-body muscle
strength and endurance. The test was performed as previously
described [20]. Briefly, mice were subjected to an 180
seconds-hanging test, during which “falling” and “reaching”
scores were recorded. When a mouse fell or reached one of
the sides of the wire, the falling score or reaching score was
diminished or increased by 1, respectively. A Kaplan-Meier-like
curve was created afterward. Moreover, the longest time
between two falls was taken as the latency-to-fall value [21].Statistical Analysis
All data were expressed as mean6 SEM, absolute values, or
percentages. For continuous variables, the variation between
groups was compared by means of nonparametric Wilcoxon
and Mann–Whitney U tests, as appropriate. When analyzing
experiments acquired with different instruments, analysis of
covariance (ANCOVA) was used to determine differences
between groups by using the instrument as a covariate. Multi-
ple logistic regression was used for trends. Statistical signifi-
cance was assumed for p< .05. The statistical analysis was
performed with SPSS for Windows version 17.0 (SPSS Inc; Chi-
cago, IL).RESULTSUnAG Upregulation in Myh6/Ghrl Transgenic MiceEnhances Muscle Regeneration
Muscle damage induces the release, within the muscle, of
several factors that activate SCs, triggering the expression of
myogenic genes, such as Myf5 and MyoD [22, 23] that even-
tually lead to the terminal differentiation of muscle precursors
and their fusion among themselves or to the existing fibers.
Muscle damage also induces, within the muscle, the expres-
sion of the ghrelin gene (Supporting Information Fig. 1) and
the preproghrelin protein [24], suggesting that its products—
ghrelin, UnAG, and obestatin—may participate in the repair
process. Accordingly, exogenously administered obestatin and
UnAG enhance muscle regeneration in CTX-injured gastrocne-
mii and in hindlimb ischemia, respectively [10, 11, 24].
Consistently, high levels of circulating UnAG in Myh6/Ghrl
transgenic mice (Tg) [14] improved muscle regeneration of TA
muscle after CTX injury (Fig. 1A–1C).
Despite no differences were noticeable between WT and
Tg in noninjured muscle CSA distribution (Supporting Informa-
tion Fig. 2A), at day 7 post CTX injury improved muscle regen-
eration in Tg mice was evidenced by a shift toward bigger
areas of regenerating (i.e., centronucleated) fibers (Fig. 1B).
This regeneration was accompanied by an increment in the
number of regenerating fibers with "2 nuclei (Fig. 1C), sug-
gesting an increase in myoblast differentiation and fusion dur-
ing regeneration, in agreement with the pro-differentiative
activity of UnAG in C2C12 myoblasts [16]. The shift toward
bigger areas and the increased myoblast fusion did not trans-
late into a hypertrophic phenotype, as at 15 days post-injury
fiber distributions of WT and Tg overlapped (Supporting Infor-
mation Fig. 2B). Consistently with the hypothesis that UnAG
induces faster recovery, injured Tg muscles displayed more
embryonal MyHC (eMyHC)-positive myofibers at day 3 post-
CTX, although at day 7 no significant differences were
observed in the number of eMyHC-expressing fibers (Support-
ing Information Fig. 2C–2E). Also, transient collagen deposi-
tion during regeneration tended to disappear more rapidly in
Tg muscles between days 7 to 15 post-injury (Supporting
Information Fig. 2F, 2G).
Though Tg mice do not overtly differ from their WT litter-
mates [14], a closer examination of their not-injured muscles
revealed a larger number of SCs, seen as Pax71 nuclei, in
both TA and QUAD from Tg animals (Fig. 1D, 1E). However,
during the phase of intense proliferation following injury, SC
number in muscles from Tg and WT were comparable (Sup-
porting Information Fig. 2H–2I). This finding suggests that a
UnAG-rich environment may confer a regenerative advantage,
at least partially by promoting post-natal SC pool formation.
In addition, transplant of SCs from GFP donor mice in muscles
of Tg or WT recipient mice resulted, 30 days later, in #80%
increase in GFP1 fibers in Tg than in WT mice (Fig. 1F, 1G),
suggesting that UnAG promotes skeletal muscle regeneration
plausibly by acting on the transplanted SCs.UnAG Promotes SC Activity and Their AsymmetricDivision
To explore in detail the effects of UnAG on SCs, we isolated
single fibers from WT muscles, thus maintaining SCs in an
original niche-like environment [25], and we cultured them in
the presence or absence of 100 nM UnAG. When cultured,
SCs undergo activation and turn on MyoD expression (Pax71/
MyoD1). After 72 hours in culture, several clusters of myo-
blasts originated from a single SC are visible on myofibers.
During this phase, the majority of activated SCs turns off Pax7
and commits to terminal differentiation (Pax7–/MyoD1),
while a small subset undergoes self-renewal, retaining Pax7
but not MyoD expression (Pax71/MyoD–) [26, 27]. UnAG
treatment within 6 hours expanded the portion of activated
SCs (Fig. 2A; Supporting Information Fig. 3A), within 72 hours
it increased the number of cells in each cluster (Fig. 2B; Sup-
porting Information Fig. 3B), and within 96 hours raised the
portion of SCs that underwent self-renewal (Fig. 2C; Support-
ing Information Fig. 3C). Cotreatment with BrdU at the begin-
ning of the experiment demonstrated that all cells underwent
DNA replication, as the totality of Pax71 cells within the
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clusters after 96 hours of UnAG treatment were also BrdU1
(Supporting Information Movies 1 and 2). Altogether, these
data indicate that UnAG enhances SC activity by promoting
their activation, expansion, and self-renewal.
SCs undergo self-renewal through asymmetric division that
gives rise to a proliferating daughter cell and a quiescent daugh-
ter cell [4]. In culture, asymmetric division generally occurs dur-
ing the first cellular division. This has been demonstrated by
culturing myofibers with cytosine b-D-arabinofuranoside (AraC),
a chemotherapic drug that selectively kills cycling cells and
spares quiescent cells. Incubation of isolated myofibers with
AraC during the first three days kills all myofiber-associated SCs,
while the addition of AraC to the culture medium from day 3
to day 5 allows the detection of AraC-resistant Pax71 SCs deriv-
ing from cells that divided at least once (Fig. 2D; [4, 28]). A
higher number of Pax71/MyoD– SCs was found in UnAG-
treated myofibers after incubation with AraC from day 3 to 5
(Fig. 2E), suggesting that UnAG acts during SC first replications,
likely regulating SC asymmetric division. Asymmetric division
can be assessed by the quantification of myofiber-associated SC
doublets, bona fide derived from a single SC after the first cell
division, in which only one of the two daughter cells is MyoD1
[4]. UnAG treatment induced a sixfold increase in the percent-
age of SC doublets in which only one cell is MyoD1 (Fig. 2F,
2G), indicating that UnAG actually promotes SC asymmetric divi-
sion. To verify whether UnAG induces self-renewal also in vivo,
Figure 1. UnAG upregulation in Myh6/Ghrl transgenic mice enhances muscle regeneration, increases satellite cell (SC) number in non-
injured muscles, and improves SC engraftment. (A): H&E representative images of WT and Myh6/Ghrl (Tg) TA muscle sections 7 days
after cardiotoxin injury. Scale bar, 100 lm. (B): CSA frequency distribution of regenerating fibers in TA. Chi-square test was used to com-
pare distributions. Trend p< .01. (CSA mean mm2: Tg 837.026 55.41; WT 559.286 15.81; p< .05). N" 4. (C): Representative images of
laminin IF with DAPI staining of WT and Tg regenerating fibers and percentage of fibers with "2 central nuclei (arrows) over the total
of regenerating fibers. Scale bar, 30 lm. Mean6 SEM *, p< .05; n" 4. (D, E): Representative images and quantification of Pax71 SCs/
mm2 (arrows) in noninjured TA (D) and QUAD (E) of WT and Tg mice. Mean6 SEM Scale bars, 30 lm. *, p< .05; TA n5 10; QUAD
n5 5. (F, G): Representative images (F) and quantification (G) of GFP1 myofibers in transplanted TA of WT and Tg mice. Scale bar, 200
lm. Mean6 SEM *, p< .05; n5 11 (WT) and 12 (Tg). Abbreviations: CSA, cross-sectional areas; DAPI, 40,6-diamidino-2-phenylindole; GFP,
green fluorescent protein; QUAD, quadriceps; TA, tibialis anterior; Tg, transgenic mice; WT, wild type mice.
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Figure 2. UnAG induces activation, proliferation, and self-renewal of SCs. (A): Percentage of MyoD1 SCs after 6 hours of treatment of
isolated myofibers with 100 nM UnAG in low proliferation medium. "20 myofibers/treatment, "40 SCs/treatment. (B): Cells per cluster
after 72 hours of treatment. "20 myofibers/treatment, "16 clusters/treatment, "2 SCs/cluster; n5 3 independent experiments. (C): Per-
centage of Pax71/MyoD– SCs after 96 hours of treatment. Mean6 SEM *, p< .05. "25 myofibers/treatment, "30 clusters/treatment, "3
SCs/cluster; n5 3 independent experiments. (D): Schematic of experiments with AraC to identify quiescent daughter SCs. (E): AraC-
resistant Pax71 cells. Mean6 SEM *, p< .05; "25 myofibers/treatment, total araC-resistant Pax71 SC n5 13 (control), 43 (UnAG); n5 3
independent experiments. (F): Representative images of SCs that underwent symmetric (control) or asymmetric (UnAG-treated) division.
Scale bar, 20 lm. (G): Percentage of asymmetric division events in SC doublets. Mean6 SEM *, p< .05; for each experiment, "22 fibers/
treatment; "22 doublets/treatment; n5 3 independent experiments. (H): Experimental design schematic: mice were daily treated with
BrdU for the first 7 days after CTX injection. Muscles were harvested 50 days after injury. (I): Representative images of tibialis anterior
transverse sections, arrow: Pax71/BrdU1 nucleus. Scale bar, 40 lm. (J): Pax71/BrdU1 nuclei normalized to the contralateral SC number.
Mean6 SEM *, p< .05; n" 8. (K): SC forced exhaustion design schematic: 10 days after three injections of CTX at 5-days intervals, EDL
fibers were isolated from injured hindlimbs and immediately fixed. (L): Number of Pax71/Myf5– SCs in 100 isolated fibers. Mean6 SEM *,
p< .05 versus multiple injured WT; §,< .05 versus not injured WT; n" 8. Abbreviations: AraC, cytosine b-D-arabinofuranoside; BrdU, 5-
bromo-20-deoxyuridine; CTX, cardiotoxin; DAPI, 40,6-diamidino-2-phenylindole; EDL, extensor digitorum longus; SC, satellite cell; UnAG,
unacylated ghrelin.
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we administered BrdU to WT and Myh6/Ghrl mice during the
phase of intense myoblast proliferation post-injury (Fig. 2H).
Since BrdU is incorporated in every cycling cell, when muscle
regeneration is fully achieved, and SC proliferation no longer
occurs, any cell positive for both BrdU and Pax7 (Fig. 2I) is a SC
that cycled at least once and then underwent self-renewal [29].
Fifty days post-injury the number of Pax71/BrdU1 SCs—nor-
malized on SC number in the contralateral, noninjured muscle—
was higher in Myh6/Ghrl than in WT muscles (Fig. 2J), demon-
strating that upregulation of UnAG enhanced SC self-renewal
also in vivo. SC self-renewal is of particular importance when
skeletal muscle is subjected to repeated cycles of degeneration/
regeneration that could lead to the progressive depletion of the
SC pool; therefore, we assessed the impact of UnAG on the
compartment of Myf5– SCs, a subpopulation of SCs that under-
goes depletion in an artificial model of SC pool exhaustion,
obtained by multiple rounds of muscle injury (Fig. 2K, [30]). EDL
fibers isolated from injured hindlimbs of WT mice displayed a
50% loss of Myf5– SCs, while fibers from Tg mice maintained
the number of Myf5– SCs (Fig. 2L), demonstrating that UnAG
helps to maintain the SC pool also upon repeated injuries.UnAG Induces Satellite Cell Self-Renewal Through ParComplex Assembly and Activation of p38
UnAG exerts its anti-atrophic and pro-differentiative effects
on skeletal muscle through activation of p38 [14, 16], a mas-
ter regulator of SC activities, as its activation mediates either
SC proliferation or differentiation [5, 31]. The role of p38 is
particularly relevant in SC self-renewal, since the asymmetric
segregation of phosphorylated p38 in dividing SCs regulates
their asymmetric division, triggering MyoD protein expression
in only one daughter cell [4, 5]. Treatment of myofibers with
UnAG for 36 hours increased the asymmetric distribution of
phosphorylated p38 in SCs without affecting total p38 uniform
distribution (Fig. 3A, 3B; Supporting Information Fig. 4).
Since in the dividing SC phospho-p38 colocalizes with the
atypical PKCk/i [4], we assessed if UnAG could also enhance
the asymmetric distribution of PKCk/i. Indeed, UnAG treat-
ment increased PKCk/i localization in one of the two SC
halves (Fig. 3C, 3D). Moreover, UnAG enhanced the asymmet-
ric cosegregation of PKCk/i and phospho-p38, seen as the
increased percentage of SCs with asymmetric distribution of
the two proteins in the same side of the cell (Fig. 3C, 3E).
Asymmetric localization of atypical PKCk/i and phospho-
p38 during SC division is closely related to the Par3-Par6-PKCk/
i complex (“Par complex”) formation during SC asymmetric
division [4]. The increased localization of both PKCk/i and
phospho-p38 observed in UnAG-treated SCs could depend on
an enhanced Par complex formation. Therefore, we assessed if
UnAG enhanced PKCk/i and PAR3 complex formation within
SCs using a PLA. We observed that indeed UnAG-treated SCs
displayed an increased number of PLA dots compared to con-
trol (Fig. 3F, 3G), indicating that UnAG enhances Par complex
assembly.
Asymmetric division depends on Par complex formation
and its asymmetric localization [4] and, accordingly, incubation
with 10 mM aurothiomalate, an inhibitor of Par complex
assembly [32], prevented the effect of UnAG on SC asymmet-
ric division (Fig. 4A).
The activation of p38 in dividing SCs affects their ability
to undergo self-renewal and, indeed, incubation of UnAG-
treated myofibers with 5 mM of p38 inhibitor SB203580,
completely abrogated UnAG effect on self-renewal (Fig. 4B).
Altogether these data suggest that UnAG promotes SC asym-
metric division and self-renewal through asymmetric phos-
phorylation of p38.
Incubation of UnAG-treated myofibers with 10 mM NF449,
a compound able to abolish the anti-atrophic activity of UnAG
in C2C12 myotubes by uncoupling Gas from G protein-cou-
pled receptors (GPCRs) [14], abrogated the increment of atyp-
ical PKC/PAR3 complex induced by UnAG (Fig. 4C, 4D),
supporting the hypothesis that UnAG acts through a Gas–cou-
pled GPCR, as previously suggested [14].Upregulation of Circulating UnAG Protects DystrophicMuscles Architecture and Functionality
The improved muscle regeneration in Myh6/Ghrl mice and
enhanced SC activity within the muscle of Myh6/Ghrl mice
and in response to UnAG treatment suggest that increase in
UnAG may be beneficial for muscle diseases such as dystro-
phies, in which the lack of dystrophin impacts both on muscle
fragility and on SC function, leading to chronic degeneration
and impaired regeneration [18, 33]. To test the hypothesis
that upregulation of UnAG circulating levels protects dystro-
phic muscles from deterioration, we crossed dystrophin-null
mdx mice with hemizygous Myh6/Ghrl mice, producing
mdxTg1 mice and mdxTg– littermate controls. Histological anal-
ysis revealed that muscles of both animal groups were under-
going regeneration, seen as high density of Pax71 SC and the
presence of eMyHC1 fibers in diaphragms (Supporting Infor-
mation Fig. 5A–5D). However, in mdxTg1 mice compared to
the mdxTg– littermates, displayed lower fiber damage in dia-
phragms of 1- and 3-month-old mice, while no differences
were evident at 6 months of age (Fig. 5A, 5B). During the
progression of the pathology, the gradual replacement of
functional muscle with collagen in diaphragm was delayed in
mdxTg1 mice compared to the mdxTg– littermates, becoming
significantly lower at 6 months of age (Fig. 5C, 5D), indicating
that upregulation of UnAG ameliorates the dystrophic pheno-
type. Consistently, hanging-wire-test scores and latency-to-fall
time, assessments of muscular functionality and endurance,
were improved in mdxTg1 mice starting from 4 months of age
(Fig. 5E, 5F), showing that the differences highlighted by his-
tological analysis translated into enhanced functional perfor-
mance. Altogether, these data show that upregulation of
circulating UnAG partially relieves the pathological condition
of mdx dystrophic mice.
To assess if these UnAG activities could have clinical rele-
vance, as a proof of concept, we exogenously administered
UnAG to dystrophic mice using adeno-associated virus (AAV)-
mediated delivery. We used the AAV9-Ghrl vector that has
been demonstrated to protect the muscle from ischemic
injury as the UnAG peptide does [11]. We injected 3.5 3 1011
vg of either AAV9-Ghrl or AAV9-LacZ in the tail vein of 3-
week-old mdx mice, when the first round of muscle degenera-
tion occurs [34], and analyzed the effect on muscles at 3
months of age. Ghrelin upregulation in muscles was con-
firmed by real-time RT-PCR (Supporting Information Fig. 6A,
6B). Analysis of diaphragms revealed less muscle damage (Fig.
5G, 5H) and collagen deposition (Fig. 5I, 5J) in AAV9-Ghrl-
injected mice compared to the AAV9-LacZ-injected controls.
Altogether, these data indicate that UnAG treatment is
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Figure 3. UnAG induces asymmetric localization of phospho-p38 and PKCk/i within the satellite cell and increases PAR3-PKCk/i complex for-
mation. (A): Representative images and (B) quantification of asymmetric distribution of phospho-p38T180/Y182 in UnAG-treated versus
untreated (control) SCs. Cells over the dashed line display at least 50% more phospho-p38T180/Y182 in one half of the nucleus compared to the
other half. Mean6 SEM *, p< .05; for each experiment "30 fibers/treatment, "34 SCs/treatment; n5 3 independent experiments. Scale bar,
5 lm. (C): Representative images of PKCk/i and phospho-p38T180/Y182 distribution in control (top) and UnAG-treated (bottom) SCs (CD341).
Scale bar, 5 lm. (D): Quantification of asymmetric distribution of PKCk/i in UnAG-treated versus untreated (control) SCs. Cells over the dashed
line display at least 50% more PKC in one half of the nucleus compared to the other half. **, p< .01; for each experiment "30 fibers/treat-
ment, "28 SCs/treatment; n5 3 independent experiments (E): Correlation between the asymmetric distribution of PKCk/i (x-axis) and phos-
pho-p38T180/Y182 (y-axis) in control (left) versus UnAG-treated (right) SCs. Each dot denotes a single satellite cell. The bottom-left shadowed
quadrants contain the SCs with both phospho-p38T180/Y182 and PKCk/i uniformly distributed. Total SCs counted n5 202 (control), 188 (UnAG-
treated). (F): Representative images of the PLA-detected complexes of PAR3 and PKCk/i (red) in control (top) versus UnAG-treated (bottom)
SCs (CD341, green). Nuclei stained with DAPI. Scale bar, 5 lm. (G): Quantification of the PLA dots per single satellite cell in control versus
UnAG-treated SCs. Mean6 SEM *, p< .05; for each experiment, "30 fibers, nuclei" 69 (control), "70 (UnAG); n5 3 independent experi-
ments. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; PLA, proximity ligation assay; SC, satellite cells; UnAG, unacylated ghrelin.
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effective even after the onset of muscle degeneration, sup-
porting the idea that UnAG administration could represent a
potential treatment for muscular dystrophies.UnAG Enhances Dystrophin-Null Satellite Cell Self-Renewal and Myogenic Commitment
To assess the direct effect of UnAG on dystrophic SCs, we iso-
lated EDL fibers from dystrophin-null mdx and WT mice, and
we cultured them in the presence or absence of 100 nM
UnAG for 96 hours. The number of Pax71/MyoD– SCs was
60% lower in mdx fibers compared to the WT ones, indicating
an intrinsic self-renewal defect of dystrophin-deficient SCs, in
agreement with previously reported data [19]; however, UnAG
significantly raised the Pax71/MyoD– SC portion in both WT
and mdx fibers (Fig. 6A, 6B). The relative increase of quiescent
SCs, of about 50%, was the same in both WT and mdx fibers,
indicating that UnAG promotes SC self-renewal independently
from the presence of dystrophin. Also, UnAG enhanced the
number of myogenin-expressing SCs in mdx myofibers cul-
tured for 72 hours (Fig. 6C, 6D), indicating that the increase
of quiescent SCs does not imply an unbalance between self-
renewal and myogenic commitment.
The sustained muscle regeneration in mdx mice is empha-
sized by the huge expansion of SCs that, however, in the long
run, leads to the depletion of the SC pool. Although no signif-
icant differences in the number of SCs are evident in mdxTg1
mice compared to mdxTg– muscles at 1- to 6-months-old ani-
mals (Supporting Information Fig. 5A, 5B), in diaphragms of
12-month-old mice we observed that the exhaustion of SC
pool, characteristic of the advanced pathology [19], was less
pronounced in mdxTg1 mice compared to mdxTg– mice (Fig.
6E, 6F), coherently with the concept that UnAG promotes SC
Figure 4. UnAG-induced satellite cell asymmetric division and self-renewal is mediated by Par complex assembly-p38 activation and
occurs through a Gas-coupled GPCR. (A): Percentage of asymmetric division events in SC doublets after 48 hours of UnAG treatment in
the presence/absence of 10 lM ATM, an inhibitor of atypical PKCk/i-Par6 complex formation. Mean6 SEM *, p< .05; "20 fibers/treatment,
"22 doublets/treatment; n5 4 independent experiments. (B): Percentage of Pax71/MyoD–SCs after 96 hours of UnAG treatment in the
presence/absence of 5 lM p38 inhibitor SB203580. Mean6 SEM *, p< .05 versus DMSO-treated control; "25 myofibers/treatment, "50
clusters/treatment, "3 SCs/cluster; n5 2 independent experiments. (C): Representative images of PLA-detected complexes of PAR3 and
PKCk/i (red) in control versus UnAG-treated SCs (CD341, green) in the presence or absence of 10 lM NF499. Nuclei stained with DAPI. Scale
bar, 5 lm. (D): Quantification of the PLA dots per satellite cell. Mean6 SEM *, p< .05; "30 fibers; n nuclei5 72 (control), 70 (UnAG), 81
(NF499), 45 (NF4991UnAG); n5 2 independent experiments. Abbreviations: ATM, aurothiomalate; DAPI, 40,6-diamidino-2-phenylindole; PLA,
proximity ligation assay; SC, satellite cells; UnAG, unacylated ghrelin.
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Figure 5. Unacylated ghrelin upregulation in mdx mice attenuates the dystrophic phenotype. (A): Representative images and (B) quan-
tification of EBD uptake in diaphragms of 1- to 6-month-old mdxTg– and mdxTg1 mice. Scale bar, 200 lm. Mean6 SEM **, p< .01 ver-
sus mdxTg–; n5 7 (mdxTg–) and 6 (mdxTg1). (C): Representative images of Masson trichrome staining and (D) quantification of collagen
deposition in the diaphragm of 1- to 6-month-old mdxTg1 and mdxTg– mice. Scale bar, 200 lm. Mean6 SEM *, p< .05; n5 7. (E, F):
Muscular functionality measured by hanging wire test scores (E) and average latency-to-fall time (F) of 4-month-old mdxTg– and mdxTg1
mice. Mean6 SEM; *, p< .05 and **, p< .01 versus mdxTg–; n5 20. (G): Representative images and (H) quantification of Evan Blue Dye
uptake in AAV9-LacZ- or AAV9-Ghrl-transduced diaphragms of 3-month-old mdx mice. Scale bar, 200 lm. Mean6 SEM *, p< .05 versus
AAV9-LacZ-transduced muscles; n5 5. (I): Representative images and (J) quantification of collagen deposition in AAV9-LacZ- and AAV9-
Ghrl-transduced diaphragms of 3-month-old mdx mice. Scale bar, 200 lm. Mean6 SEM *, p< .05 versus AAV9-LacZ-transduced muscles;
n5 5. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; EBD, Evans blue dye.
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Figure 6. UnAG improves dystrophin-null SCs activity. (A): Representative images of Pax7 and MyoD IF and DAPI counterstaining of SCs
on myofibers isolated from WT or mdx extensor digitorum longus (EDL) muscles and treated with 100 nM UnAG for 96 hours. Scale
bars, 20 lm. (B): Percentage of Pax71/MyoD– SCs after 96 hours of treatment of WT or mdx myofibers with 100 nM UnAG. Mean6
SEM **, p< .01 versus. WT control, §, p< .01 versus WT control, and #, p< .01 versus mdx control. "25 myofibers/treatment, "14
cluster/treatment, "3 SCs/cluster; single experiment. (C): Representative images of Myog and Sdc4 IF and DAPI counterstaining of SCs
on myofibers isolated from mdx EDL muscles and treated with 100 nM UnAG for 72 hours. Scale bar, 20 lm. (D): Number of Myog1/
Sdc4- SCs per fibers after 72 hours of treatment of mdx myofibers with 100 nM UnAG. *, p< .01 versus mdx, "45 myofibers/treatment,
total Myog1/Sdc4- SCs5 95 (control), 140 (UnAG); n5 3 independent experiments. (E): Representative images (scale bar, 200 lm) and(F) quantification of Pax71/MyoD– (arrows) cells/mm2 in diaphragm sections of 12-month-old mdxTg1 and mdxTg– mice. Mean6 SEM §,
p< .05 versus WT; *, p< .05 versus mdxTg–; n5 7. (G): Representative images (scale bar, 20 lm) and (H) percentage of Pax71/MyoD–
SCs on myofibers isolated from aged (12 months) WT, mdxTg–, and mdxTg1 cultured for 96 hours in low proliferation medium. §, p< .01
versus WT control and *, p< .05 versus mdxTg–, "23 myofibers/group, "23 cluster/group, "3 SCs/cluster; single experiment. Abbreviations:
DAPI, 40,6-diamidino-2-phenylindole; Myog, myogenin; SCs, satellite cells; Sdc4, syndecan 4; UnAG, unacylated ghrelin; WT, wild type mice.
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self-renewal. Consistently, after 96 hours in culture, myofibers
from mdxTg1 mice displayed twice as much Pax71/MyoD–
SCs, likely reflecting an initial higher content of functional SCs
(i.e., able to undergo self-renewal) compared to mdxTg– mice
(Fig. 6G, 6H).DISCUSSION
The data herein presented demonstrate that UnAG acts on
SCs enhancing their activation, differentiation, and self-
renewal. SC self-renewal depends on either symmetric or
asymmetric division of a subpopulation of noncommitted pro-
genitors. For instance, Wnt7a promotes SC self-renewal
through induction of their symmetric division via a noncanoni-
cal, planar-cell-polarity pathway [35] and without affecting SC
differentiation. On the contrary, UnAG promotes SC self-
renewal enhancing at the same time their terminal differenti-
ation, as shown by the increase of fusion index on cultured
SCs (Supporting Information Fig. 7). This effect is likely a con-
sequence of UnAG-induced increase on SC asymmetric divi-
sion that simultaneously maintains the stem compartment of
MyoD– SCs and expands the number of the committed
MyoD1 myoblasts able to respond to the pro-differentiative
activity of UnAG, in agreement with the effect observed on
C2C12 [16].
SC asymmetric division is sustained by the Par polarity
complex that includes the atypical PKCk/i, which controls the
asymmetric activation of p38 that, in turn, triggers MyoD
expression and myogenic commitment in only one daughter
cell [4, 5]. Phosphorylated p38 plays a key role in asymmetric
division [4]; indeed, loss or reduction of asymmetric segrega-
tion of phosphorylated p38 and its diffuse activation within
the SC from aged mice determines a strong decline of asym-
metric division events and the consequent impairment of SC
self-renewal ability [28].
UnAG promotes the asymmetric cosegregation of PKCk/i
and phospho-p38 and the Par complex assembly in myofiber-
associated SCs. In addition, uncoupling of PKCk/i from the Par
complex and inhibition of p38 activity impair UnAG-induced
asymmetric division and self-renewal, indicating that UnAG trig-
gers signaling pathways contributing to the formation of the
polarity complex. The finding that uncoupling of Gas from
GPCRs impairs the UnAG-stimulated assembly of the polarity
complex suggests that UnAG acts in SCs through a similar or
the same receptor mediating its anti-atrophic activity in C2C12
myotubes [14]. The lack of knowledge on the identity of UnAG
receptor hinders deeper investigations on the signaling mecha-
nisms mediating its activity in SCs. Nevertheless, UnAG stimu-
lates cAMP and PKA [36], which are linked to the activation of
the polarity kinase LKB1 and to the formation of the polarity
complex [37–39], thus leading to the speculation that cAMP/
PKA pathway may contribute to UnAG polarizing signal in SCs.
The expansion of SCs through asymmetric division and the
enhancement of their differentiation elicited by UnAG underline
its ability to enhance skeletal muscle regeneration (Fig. 1A–1C,
[10, 11]), consistently with the hypothesis that ghrelin induction
in the injured muscle contributes to the repair process. Indeed,
ghrelin is rapidly and transiently induced upon muscle damage
[24]. However, the identification of the cells responsible for
ghrelin expression is hampered by the poor specificity of the
available anti-preproghrelin antibodies, which recognize positive
signals in injured skeletal muscle of ghrelin KO mice (data not
shown). As ghrelin is highly expressed in neutrophils, which are
recruited to the site of damage with similar kinetics as ghrelin
induction [40, 41], we can speculate that neutrophils may be
responsible for ghrelin upregulation observed in muscles after
injury. Altogether these findings suggest that UnAG is part of
the damage-induced tissue repair process.
The more efficient engraftment of donor SCs in Tg mice
(Fig. 1F, 1G) is consistent with a direct effect on SC functional-
ity as well. However, the better engraftment may also depend
on UnAG anti-inflammatory activity. Indeed, in skeletal muscle,
UnAG inhibits TNF-a expression following either burn injury or
high-fat diet [12, 15]. Furthermore, we cannot rule out that
the increased engraftment of SCs in Tg muscle may partially be
due to an anti-apoptotic effect of UnAG on transplanted SCs
since UnAG inhibits apoptosis in both cardiomyocytes and myo-
blasts through activation of autophagy [11, 12].
Altogether, these findings indicate that UnAG regulates
multiple steps of muscle regeneration by stimulating asym-
metric division-mediated SC self-renewal and by promoting
terminal differentiation and fusion of proliferating myoblasts.
The capacity of UnAG to induce SC self-renewal also in vivo
translates in the ability to preserve the quiescent SC pool
upon repeated cycles of injury/regeneration.
UnAG pro-regenerative effect on skeletal muscle and its
activity on SCs may account for the less severe phenotype
observed in dystrophic mice with high levels of circulating or
local UnAG in mdxTg1 or AAV-Ghrl-treated mdx mice, respec-
tively. However, the anti-inflammatory, and, consequently, the
anti-fibrotic activities of UnAG [42, 43] could be likewise rele-
vant to explain the protection of tissue architecture and the
amelioration of muscle performance. In addition, as defective
basal autophagy contributes to the dystrophic phenotype [44,
45], UnAG-enhanced autophagy may likewise contribute to its
protective activity in mdx mice.
In dystrophy, the exhaustion of the SC pool has been
assumed to cause the failure of regeneration to keep up with
muscle damage. However, in both human and mice SC pool
exhaustion likely sets in only at late stages of the pathology as a
consequence of defective SC self-renewal [19]. Furthermore, dys-
trophic muscles show an increased overall number of SCs,
although, within this figure, the portion of quiescent SCs is
reduced, reflecting an ongoing regeneration [18, 19, 46]. It is
plausible that the defect in muscle regeneration of mdx mice
resides at least in part in the defective asymmetric division of
dystrophin-null SC that translates in an imbalance between SCs
and committed myoblasts able to terminally differentiate and
repair the damaged muscle [18, 33]. The finding that UnAG, in
dystrophin-null SCs, enhances their self-renewal and increases the
number of committed myoblasts suggests that UnAG promotes
SC asymmetric division by activating pathways that are indepen-
dent of dystrophin expression. Thus, we can speculate that the
increase in the absolute number of functional SCs triggered by
UnAG in mdx mice may increase the number of committed pro-
genitors, thus sustaining the better muscle regeneration and
improved dystrophic phenotype observed in mdxTg1 mice.
Altogether, these data suggest that increase in either circu-
lating or local UnAG levels could delay the progression of the
disease. A therapeutic approach would presumably involve the
chronic administration of UnAG to dystrophic patients.
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Although the receptor through which UnAG exerts its biological
activities remains elusive, UnAG has been recently used in clini-
cal trials to assess its metabolic effects, and it was reported
that the peptide was well tolerated, and no serious adverse
events occurred during the studies [47–51]; therefore, UnAG
could be a realistic adjuvant treatment in the near future to
help to preserve muscles of dystrophic patients.SUMMARY
UnAG affects in multiple ways SC physiological behavior and
enhances skeletal muscle regeneration. These activities result
in an overall beneficial effect in dystrophic mdx mice, seen as
an improved condition of muscles and a better physical per-
formance, and suggest that UnAG could be regarded as a real-
istic therapeutic strategy for muscular dystrophies, either as a
self-sufficient treatment or as an adjuvant with other
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